At a glance
- Originator Servier
- Class Anti-inflammatories; Antiasthmatics
- Mechanism of Action Bradykinin B2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Inflammation
Most Recent Events
- 23 Jul 1998 No-Development-Reported for Asthma (Unknown route)
- 23 Jul 1998 No-Development-Reported for Inflammation (Unknown route)
- 02 Nov 1995 New profile